Logo

Call us today 212-583-0100

ir@enzo.com    

  • Home
  • Corporate
    • Investor Information
    • About Us
    • Officers & Directors
    • Press Releases
    • Careers
  • Therapeutics
    • About ENZO Therapeutics
      • Overview
      • Our Mission
      • Our Strategy
      • Partnering
      • Maps and Directions
      • Contact Us
    • Therapeutic Market
      • Overview
      • Inflammatory Bowel Disease
      • Uveitis
      • HIV
      • Bone Disorders
      • Diabetes
    • Technologies
      • Immune Regulation
      • Gene Technology
      • Cell Signaling Modulation
    • Pipeline
      • Overview
      • Cell Signaling Modulation
        • Diabetes
        • Preclinical Studies for Bone Disorders
      • Immune Regulation
        • Alequel ™
        • Optiquel ™
      • Gene Technology
        • Stealth Vector™ HGTV43™
  • Clinical Labs
  • Life Sciences
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Sep 12, 2007 8:22am EDT

Enzo Biochem, Inc. Comments on Business and Legal Activities

Sep 07, 2007 8:18am EDT

Enzo Biochem, Inc. Files Appeal to Federal Court Decision

Jun 11, 2007 4:15pm EDT

Enzo Biochem Reports Third Quarter Results

Jun 07, 2007 3:00pm EDT

Enzo Biochem Schedules Teleconference to Discuss Third Quarter Results for Tuesday June 12, 2007, at 8:30 a.m. E.T.

Jun 05, 2007 11:26am EDT

Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.

May 30, 2007 10:00am EDT

Enzo Biochem Unit to Acquire Axxora Life Sciences, Inc. Global Reagent Manufacturer and Marketing Company

May 22, 2007 11:30am EDT

Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn's Disease

May 03, 2007 12:00pm EDT

Enzo Biochem Announces Supply and Royalty Bearing Cross-Licensing Agreements with Abbott

Mar 12, 2007 4:10pm EDT

Enzo Biochem Reports Results for Fiscal 2007 Second Quarter and Six Month Periods

Mar 08, 2007 3:32pm EST

Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results for Tuesday March 13, 2007, at 8:30 AM E.T.

  • Previous
  • 1…
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Meta

  • Privacy Policy
  • Intellectual Property
  • Safe Harbor Statement
  • HIPAA Policy
  • Web Feedback

Contact us

Enzo Biochem Executive Offices
81 Executive Blvd, Suite 3
Farmingdale, NY
11735
USA

212-583-0100

info@enzo.com

Copyright ©2023 Enzo Biochem Inc.